Lapatinib: clinical benefit in patients with HER2-positive advanced breast cancer

J.R. Kroep, S.C. Linn, E. Boven, H.J. Bloemendal, J. Baas, I.A.M. Mandjes, J.A. van den Bosch, W.M. Smit, H. de Graaf, C.P. Schroder, G.J. Vermeulen, W.C.J. Hop, J.W.R. Nortier

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)371-376
JournalNetherlands Journal of Medicine
Volume68
Issue number9
Publication statusPublished - 2010

Cite this

Kroep, J. R., Linn, S. C., Boven, E., Bloemendal, H. J., Baas, J., Mandjes, I. A. M., ... Nortier, J. W. R. (2010). Lapatinib: clinical benefit in patients with HER2-positive advanced breast cancer. Netherlands Journal of Medicine, 68(9), 371-376.